Lamivudine in the treatment of acute hepatitis B

Case Reports

R Reshef et al. N Engl J Med. 2000.

. 2000 Oct 12;343(15):1123-4.

doi: 10.1056/NEJM200010123431513.

No abstract available

Comment in

Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B.
Gupta S, Piraka C, Jaffe M. Gupta S, et al. N Engl J Med. 2001 May 24;344(21):1645-6. doi: 10.1056/NEJM200105243442118. N Engl J Med. 2001. PMID: 11374371 No abstract available.

A preliminary trial of lamivudine for chronic hepatitis B infection.
Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. Dienstag JL, et al. N Engl J Med. 1995 Dec 21;333(25):1657-61. doi: 10.1056/NEJM199512213332501. N Engl J Med. 1995. PMID: 7477217 Clinical Trial.
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF. Lai CL, et al. N Engl J Med. 1998 Jul 9;339(2):61-8. doi: 10.1056/NEJM199807093390201. N Engl J Med. 1998. PMID: 9654535 Clinical Trial.
Lamivudine as initial treatment for chronic hepatitis B in the United States.
Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Dienstag JL, et al. N Engl J Med. 1999 Oct 21;341(17):1256-63. doi: 10.1056/NEJM199910213411702. N Engl J Med. 1999. PMID: 10528035 Clinical Trial.